La Jolla Institute receives $1 million gift- landmark gift supports the merging of precision medicine and immunotherapy
LA JOLLA, CA – The La Jolla Institute for Immunology (LJI) has received a $1 million gift from John Major,
LA JOLLA, CA – The La Jolla Institute for Immunology (LJI) has received a $1 million gift from John Major,
LA JOLLA, CA – The La Jolla Institute for Immunology (LJI) is pleased to announce that an international team led
LA JOLLA, CA— HardTech Labs LLC (HTL) has partnered with La Jolla Institute for Immunology (LJI) to establish a joint
Members of the TET (short for ten-eleven translocation) family have been known to function as tumor suppressors for many years,
LA JOLLA, CA—The ebb and flow of intracellular calcium concentrations is a universal mode of communication in mammalian cells. Among
LA JOLLA, CA— Dr. Mitchell Kronenberg, President and Chief Scientific of Officer of the La Jolla Institute for Immunology has
LA JOLLA, CA—Multiple sclerosis, a debilitating neurological disease, is triggered by self-reactive T cells that successfully infiltrate the brain and
LA JOLLA, CA— One goal of immunotherapy is to rally a patient’s often over‐burdened immune cells to effectively attack a
LA JOLLA, CA—Pandurangan Vijayanand (Vijay), M.D., Ph.D., has been appointed to the position of associate professor in the Division of
LA JOLLA, CA—The La Jolla Institute for Immunology (LJI) is pleased to announce that visionary business leader Richard S. Bodman
LA JOLLA, CA—Researchers at the La Jolla Institute (LJI) for Allergy and Immunology identified a unique subset of helper T
LA JOLLA, CA—The La Jolla Institute for Immunology is pleased to announce that Larry Spitcaufsky and Hunt Pettit have been